Print Page

Multiple Sclerosis: Subtypes, Symptoms, Diagnosis, Treatment Document List

Summary: Our library below features 50 published articles, research papers, and documents from the Disabled World Multiple Sclerosis (MS) category. Although some of these documents may have since been updated, re-written, replaced, or revised, they are sorted by their original publish date. The most recent publications are listed at the top of the table with older articles being listed in descending order by the date they were created. You can also receive our latest communications as soon as they are released by subscribing to our Multiple Sclerosis (MS) RSS feed.

Multiple Sclerosis (MS) Publications

New Multiple Sclerosis Treatment Clinical Trial Begins Enrollment
Clinical trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) begins enrollment.
Publish Date: 2020-01-07 - Updated: 2020-02-10

Stigma Increases Risk of Depression for People with Multiple Sclerosis
Those with MS who feel stigmatized are more likely to have depression, having a support system of friends and family and a sense of autonomy may help reduce the harmful effects of stigma..
Publish Date: 2018-03-01 - Updated: 2018-03-28

$7M MS Progression Cohort to Research Multiple Sclerosis in Canada
Research proposals will invite researchers to establish a Canadian cohort of people living with MS to study progression in the disease.
Publish Date: 2017-03-31

How Can We Predict Whose Multiple Sclerosis Will Worsen?
Multiple Sclerosis study brings us closer to understanding which older adults with MS may be at higher risk of getting worse.
Publish Date: 2017-03-20

Cladribine Significantly Reduces Brain Atrophy in Patients with Multiple Sclerosis
Phase III CLARITY study data revealed significant reduction in brain atrophy in patients on short course of investigational Cladribine Tablets over two years.
Publish Date: 2017-02-13 - Updated: 2020-03-06

Multiple Sclerosis Onset Age Linked to Geographic Latitude
Study finds the age at which symptoms of multiple sclerosis (MS) first start is strongly linked to latitude.
Publish Date: 2016-11-07

Stem Cells Show Reversal of Disability in Multiple Sclerosis
Stem cell treatment improves established disability in patients with progressive MS and shows there is hope future treatment is possible.
Publish Date: 2016-04-15 - Updated: 2016-05-07

Multiple Sclerosis Research Progress and Initiatives
Summary of significant 2015 multiple sclerosis research progress and initiatives from The National Multiple Sclerosis Society.
Publish Date: 2015-12-29 - Updated: 2020-11-25

New Multiple Sclerosis (MS) Drug Target Discovered
New research could lead to the development of new types of drugs to treat Multiple Sclerosis (MS).
Publish Date: 2015-02-18 - Updated: 2021-09-01

Multiple Sclerosis - HPV Vaccination No Increased Risk
Follow-up of girls and women who received human papillomavirus (HPV) vaccination found no increased risk for these disorders.
Publish Date: 2015-01-11

A Step Closer to Cell Therapy for MS Patients
Research scientists are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patients own cells.
Publish Date: 2014-07-24 - Updated: 2016-04-15

Link Between Dental Mercury Fillings and MS Examined
Case discovered that her inability to walk and other MS symptoms were triggered by her dental mercury fillings.
Publish Date: 2013-01-03 - Updated: 2021-06-14

FAMPYR Now Available in Canada for Improvement of Walking in MS
Health Canada approved FAMPYRA on February 10, 2012 for the symptomatic improvement of walking in adult MS patients with walking disability.
Publish Date: 2012-04-12

Symptom Relief in MS Patients Seen by Interventional Radiologists
Minimally invasive endovascular treatment for CCSVI may produce significant improvement in physical and mental quality of life in individuals with MS.
Publish Date: 2012-03-27 - Updated: 2022-04-09

Major Breakthrough in Multiple Sclerosis Found Using Upright MRI
Diagnostic breakthrough in multiple sclerosis reveals cause may be bio-mechanical related to earlier trauma to the neck resulting in obstruction of cerebrospinal fluid flow.
Publish Date: 2011-10-06 - Updated: 2016-04-15

Breakthrough in Search for Multiple Sclerosis Treatment
Molecular mechanism could bring about the development of new treatments for Multiple Sclerosis (MS).
Publish Date: 2011-06-30

Minimally Invasive Treatment for MS Patients
Endovascular therapy or angioplasty is the nonsurgical procedure of threading a thin tube into a vein or artery to open blocked or narrowed blood vessels.
Publish Date: 2011-06-23

Shingles May Be Related to Elevated Risk of Multiple Sclerosis
There is epidemiological evidence that some herpes viruses may contribute to multiple sclerosis (MS) occurrence.
Publish Date: 2011-06-12 - Updated: 2015-01-14

Viagra May Reduce MS Symptoms
Viagra drastically reduces multiple sclerosis symptoms in animal models with the disease.
Publish Date: 2011-05-19

SR1001 Compound Halts Progression of Multiple Sclerosis (MS)
Scientists develop compound that effectively halts progression of multiple sclerosis (MS), the discovery also holds promise for other autoimmune disorders.
Publish Date: 2011-04-18 - Updated: 2022-04-21

Disability Timeline for Progressive Multiple Sclerosis (MS)
By noting the presence of markers in a diagnostic test, researchers predict whether patients will suffer faster onset of disability and counsel them to help ease anxiety.
Publish Date: 2011-04-15 - Updated: 2022-04-21

Novartis Therapy Gilenya Reduced Risk of MS Disability Progression
Gilenya delayed progression of disability both for patients who were previously treated for their MS and for patients who had not received prior treatment.
Publish Date: 2011-04-11

Treating Multiple Sclerosis Damage to Nerve Cells
Multiple sclerosis is a seriously disabling autoimmune disease that can lead to disturbance or loss of sensory function voluntary movement vision and bladder control.
Publish Date: 2011-03-31 - Updated: 2022-04-29

Monitoring System for Multiple Sclerosis - Canada
People living with MS need more information to make the best choices for the benefit of their health.
Publish Date: 2011-03-30

MS - How Do You Put a Face on a Disease that Affects Each Person Differently
Multiple sclerosis is a life altering disease that affects each person in a unique and different way.
Publish Date: 2011-03-14 - Updated: 2017-03-20

Multiple Sclerosis Oral Treatment Approved in Canada
Gilenya (fingolimod) is the first disease modifying oral therapy developed for the relapsing-remitting form of multiple sclerosis (MS).
Publish Date: 2011-03-10 - Updated: 2016-06-13

Fumaric Acid Salts for Psoriasis May Help Multiple Sclerosis
Fumaric acid salts used against severe psoriasis may also have a favorable effect on Multiple Sclerosis as a result of their TH2 polarizing mechanisms.
Publish Date: 2011-03-07 - Updated: 2018-03-16

Reduced Levels of Neurotransmitter in MS
Damage to a particular area of the brain and a consequent reduction in noradrenaline are associated with multiple sclerosis.
Publish Date: 2011-02-13

Histamine May be Possible Drug Target for Multiple Sclerosis
Histamine could be an important molecule to developing new treatments for multiple sclerosis (MS).
Publish Date: 2011-01-31

Progress in Multiple Sclerosis Research
Multiple Sclerosis (MS) Progress was made toward finding ways to restore function and improving quality of life through exercise meditation rehabilitation and medications.
Publish Date: 2010-12-20 - Updated: 2023-09-19

New Possibility of Reversing Damage Caused by MS
Damage caused by multiple sclerosis could be reversed by activating stem cells that can repair injury in the central nervous system.
Publish Date: 2010-12-05

Multiple Sclerosis Will Become a Controlled Disease
The complexity of the immune system and nervous system turn Neuroimmunology into one of the most exciting fields of modern biomedicine.
Publish Date: 2010-10-28

Ocrelizumab Shows Significant Reduction in Multiple Sclerosis Disease Activity
Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients.
Publish Date: 2010-10-17 - Updated: 2017-02-13

Asthma Medication May Benefit Patients with Multiple Sclerosis
Albuterol sulfate used to treat bronchospasm in asthma may decrease interleukin-12 levels.
Publish Date: 2010-09-13 - Updated: 2016-06-13

CIHR Makes Recommendations on Canadian MS Research Priorities
Meeting of leading North American experts in multiple sclerosis (MS) to identify research priorities for Canada.
Publish Date: 2010-09-01

Bone Marrow Stem Cells in MS Show Promise
Trial to test bone marrow stem cell therapy with patients with multiple sclerosis shown to have possible benefits for treatment of the disease.
Publish Date: 2010-08-28 - Updated: 2016-04-15

SIR Supports Research for New MS Treatments
Society of Interventional Radiology would like to be actively involved in developing evidence-based therapies for the potential treatment of patients with multiple sclerosis.
Publish Date: 2010-08-26

Encouraging Results for Multiple Sclerosis Treatment
Hard To Treat Diseases (HTDS.PK) Scientists report results that are encouraging for the future of Multiple Sclerosis Treatment.
Publish Date: 2010-06-03

Join the Movement to End Multiple Sclerosis
Join the Movement to End Multiple Sclerosis During MS Awareness Week March 8-14, 2010.
Publish Date: 2010-03-08 - Updated: 2010-07-03

Ampyra for Adults with Multiple Sclerosis
FDA approves Ampyra (dalfampridine) drug to improve walking in patients with multiple sclerosis (MS).
Publish Date: 2010-01-24 - Updated: 2012-10-10

New Drug Cladribine for Multiple Sclerosis Shows Promise
Major trial of oral drug Cladribine has shown it significantly reduces relapse and deterioration of multiple sclerosis (MS).
Publish Date: 2010-01-20 - Updated: 2018-03-16

National MS Society Continues to Propel Research Forward to End MS
Several papers published this year provided more evidence that starting on MS therapies early after disease onset, or even before a definite diagnosis, can pay off later by delaying disease progression.
Publish Date: 2009-12-23 - Updated: 2023-09-19

Multiple Sclerosis Relapses and Severe Disability
People with multiple sclerosis who have relapses within five years of onset have more severe disability in the short term.
Publish Date: 2009-11-05

Possible New Underlying Cause of Multiple Sclerosis
Research study could overturn the prevailing wisdom on the cause of multiple sclerosis (MS).
Publish Date: 2009-10-25

Genes Identified as Potential Therapeutic Targets for Multiple Sclerosis
Study finds two genes associated with good central nervous system repair in multiple sclerosis.
Publish Date: 2009-09-11

Brain Disease Virus Found in Natalizumab Treated MS Patients
Virus responsible for rare brain disease found to be reactivated in multiple-sclerosis patients being treated with natalizumab.
Publish Date: 2009-09-10 - Updated: 2010-07-11

Researchers Successfully Reverse Multiple Sclerosis
A new experimental treatment for multiple sclerosis (MS) completely reverses the devastating autoimmune disorder.
Publish Date: 2009-08-11

Antegren Drug for Relapsing MS
Antegren for multiple sclerosis is a monoclonal antibody that is given by monthly infusion into a vein.
Publish Date: 2009-02-27 - Updated: 2015-01-28

Naltrexone Treats Multiple Sclerosis - But Sufferers Can't Get it
The drug Naltrexone has stopped the progression of Multiple Sclerosis and enhanced the quality of life for Multiple Sclerosis sufferers.
Publish Date: 2009-02-27 - Updated: 2018-03-16

Drug Improves Mobility For Some Multiple Sclerosis Patients
Experimental drug fampridine 4-aminopyridine improves walking ability in some individuals with multiple sclerosis MS.
Publish Date: 2009-02-27

Share This Information To:
𝕏.com Facebook Reddit


Disabled World is an independent disability community founded in 2004 to provide disability news and information to people with disabilities, seniors, their family and/or carers. See our homepage for informative reviews, exclusive stories and how-tos. You can connect with us on social media such as X.com and our Facebook page.

Permalink: <a href="https://www.disabled-world.com/health/autoimmunediseases/ms-2/">Multiple Sclerosis: Subtypes, Symptoms, Diagnosis, Treatment Articles</a>

Cite This Page (APA): Disabled World. (2023, January 30). Multiple Sclerosis: Subtypes, Symptoms, Diagnosis, Treatment. Disabled World. Retrieved September 22, 2023 from www.disabled-world.com/health/autoimmunediseases/ms-2/

Disabled World provides general information only. The materials presented are never meant to substitute for qualified professional medical care, nor should they be construed as such. Funding is derived from advertisements or referral programs. Any 3rd party offering or advertising does not constitute an endorsement.